#Europe

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

These drugs are approved to treat all six major genotypes of hepatitis C.

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.

This finding is from a program that sought to provide blanket treatment to Iceland’s hep C population.

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

Nearly all those who have completed follow-up in an ongoing Italian study have been cured.

HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.

This finding stresses the need to reduce the risk of sexual transmission of hep C among HIV-positive men who have sex with men.

A trio of British studies projected the impact of programs that provide clean injection-drug materials to people who inject drugs.

A recent survey of such sites found high rates of hepatitis C among patrons, but treatment for the virus was rarely offered on-site.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

It appears the liver virus may have originated in North Africa and the Middle East.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)